Comparison
3 Methylglutaconic Aciduria C3696376 vs 17q24 2 Microdeletion Syndrome C5680185
Clinical comparison between 3 Methylglutaconic Aciduria and 17q24 2 Microdeletion Syndrome for differential diagnosis and treatment planning.
3 Methylglutaconic Aciduria C3696376
A metabolic disorder causing abnormal acid buildup affecting multiple body systems including the brain. Severity varies widely among affected individuals. Care focuses on symptom management and metabolic support.
17q24 2 Microdeletion Syndrome C5680185
A rare genetic disorder caused by deletion of genetic material on chromosome 17. Individuals may have developmental delays, facial features, and other medical issues. Care is supportive and multidisciplinary.
6 comparison axes
Onset
3 Methylglutaconic Aciduria C3696376
0-10
17q24 2 Microdeletion Syndrome C5680185
0-null
Onset patterns differ
Severity
3 Methylglutaconic Aciduria C3696376
severe
17q24 2 Microdeletion Syndrome C5680185
moderate
Different severity levels
Chronic
3 Methylglutaconic Aciduria C3696376
Chronic
17q24 2 Microdeletion Syndrome C5680185
Chronic
Differing course
Communicable
3 Methylglutaconic Aciduria C3696376
No
17q24 2 Microdeletion Syndrome C5680185
No
Different transmission
Body System
3 Methylglutaconic Aciduria C3696376
metabolic
17q24 2 Microdeletion Syndrome C5680185
congenital
Same/different system
Category
3 Methylglutaconic Aciduria C3696376
metabolic
17q24 2 Microdeletion Syndrome C5680185
genetic
Different category
Bottom line
3-methylglutaconic-aciduria-C3696376 and 17q24-2-microdeletion-syndrome-C5680185 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 3 Methylglutaconic Aciduria C3696376 | 17q24 2 Microdeletion Syndrome C5680185 | Discriminating power |
|---|---|---|---|
| Metabolic decompensation | May include episodic illness, acidosis, or neurologic change; not universal. | Not a typical metabolic crisis pattern based on available description. | Moderate |
| Developmental delay | Possible when the brain is affected; severity varies widely. | Developmental delay is a described feature, with variable other issues. | Low |
| Congenital or facial features | Not established as a defining congenital pattern. | Facial features and other congenital issues may occur. | Moderate |
When to favor each condition
Choose 3 Methylglutaconic Aciduria C3696376 when
Unexplained metabolic or neurologic episodes
An organic aciduria should be considered when symptoms suggest abnormal acid metabolism.
Moderate
Abnormal organic acid result
Elevated 3-methylglutaconic acid supports further metabolic evaluation, not a diagnosis alone.
High
Multisystem course without a chromosomal finding
Metabolic testing may be prioritized, but genetic causes can coexist or overlap.
Low
Choose 17q24 2 Microdeletion Syndrome C5680185 when
Developmental delay with congenital features
A chromosomal microdeletion is more consistent with this congenital pattern.
Moderate
Suspected copy-number variant
Chromosomal microarray or equivalent testing can identify a 17q24.2 deletion.
High
Stable course without metabolic crises
Absence of crises does not exclude either condition; genetics may still be appropriate.
Low
How key tests differ
| Test | 3 Methylglutaconic Aciduria C3696376 | 17q24 2 Microdeletion Syndrome C5680185 | Interpretation |
|---|---|---|---|
| Urine organic acids | May show 3-methylglutaconic acid elevation; cutoff not specified here. | No characteristic organic acid pattern is established. | An abnormal result needs specialist confirmation and is not itself a diagnosis. |
| Chromosomal microarray | Not the primary test for this metabolic disorder. | May detect deletion of material at 17q24.2. | A confirmed deletion supports the syndrome; clinical correlation remains necessary. |
| Metabolic panel during illness | May reveal acidosis or other metabolic disturbance; exact thresholds vary. | No specific metabolic abnormality is established. | Results guide urgent care but do not distinguish all causes. |
Prognosis comparison
3 Methylglutaconic Aciduria C3696376
- Outcome
- Chronic course with widely variable severity; exact outcomes are not established.
- Factors
- Extent of metabolic and neurologic involvement and response to supportive care.
17q24 2 Microdeletion Syndrome C5680185
- Outcome
- Generally described as moderate, but individual outcomes are not established.
- Factors
- Deletion effects, developmental needs, and associated medical issues.
Time frame: Often recognized in childhood; lifelong course may occur.
Diagnosis confirmation, complications, therapies, and family support influence outlook.
Complications comparison
| Complication | Presentation |
|---|---|
| Neurologic impairment | Brain involvement and variable severity are described. Developmental delay may occur; neurologic spectrum is not fully defined. Both need individualized developmental assessment. |
| Acute metabolic illness | Possible because of abnormal acid buildup. Not described as a primary complication. Emergency evaluation is warranted for acute deterioration. |
| Associated congenital problems | Specific congenital complications are not established here. Other medical issues may accompany the deletion. Surveillance should follow confirmed findings and specialist advice. |
Patient education highlights
- HighDifferent causes
One is a metabolic disorder; the other is a chromosomal deletion. Testing, not symptoms alone, separates them.
- HighWhen to seek care
Seek urgent care for breathing difficulty, persistent vomiting, reduced alertness, seizures, or sudden worsening.
- MediumSupportive care
Care is individualized and often multidisciplinary. No dose or treatment recommendation is implied here.